IndraLab

Statements


Caspase-3 inhibitor activates USP48. 1 / 1
| 1

reach
"Western blot analysis confirmed that the caspase-3 inhibitor reduced PARP and USP48 cleavage after PR-619 treatment (Figure 2b)."